Polymorphism in generic drug product development.
D001682:Biological Availability; D002152:Calorimetry, Differential Scanning; D016206:Databases, Bibliographic; D004339:Drug Compounding; D004345:Drug Industry; D016568:Drugs, Generic / Q000737:chemistry* / Q000493:pharmacokinetics; D005079:Excipients / Q000737:chemistry; D006801:Humans; D008790:Metoprolol / Q000737:chemistry; D008968:Molecular Conformation; D010316:Particle Size; D044367:Phase Transition; D012995:Solubility; D012997:Solvents / Q000737:chemistry; D013148:Spironolactone / Q000737:chemistry; D013678:Technology, Pharmaceutical / Q000379:methods*; D016593:Terfenadine / Q000737:chemistry; D013810:Therapeutic Equivalency; D017155:Wettability
D016568:Drugs, Generic; D005079:Excipients; D012997:Solvents; D013148:Spironolactone; D016593:Terfenadine; D008790:Metoprolol